Drugnews|藥時事

LaunXP BioMed

朗齊生物醫學股份有限公司

6876 · Emerging Stock Board

LaunXP BioMed is a Taiwan Emerging Stock Board biotechnology company, as of 2026-11-01.

Pipeline

AssetTarget / mechanismStageIndicationRegionSource dateSource
LXP103—————Company disclosure
LXP105————2026-09-23Company disclosure
LXP109————2026-06-09Company disclosure

Key events

Related Drugnews articles

No related articles in this language.